1 subvariant of COVID-19 available to the public from Wednesday next week. The vaccine was an alternative for those who previously had an adverse reaction to more common mRNA COVID-19 vaccines, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback